Expansion, harvest and cryopreservation of human mesenchymal stem cells in a serum‐free microcarrier process

Human mesenchymal stem cell (hMSC) therapies are currently progressing through clinical development, driving the need for consistent, and cost effective manufacturing processes to meet the lot‐sizes required for commercial production. The use of animal‐derived serum is common in hMSC culture but has...

Descripción completa

Detalles Bibliográficos
Autores principales: Heathman, Thomas R. J., Glyn, Veronica A. M., Picken, Andrew, Rafiq, Qasim A., Coopman, Karen, Nienow, Alvin W., Kara, Bo, Hewitt, Christopher J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029583/
https://www.ncbi.nlm.nih.gov/pubmed/25727395
http://dx.doi.org/10.1002/bit.25582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029583/
https://www.ncbi.nlm.nih.gov/pubmed/25727395
http://dx.doi.org/10.1002/bit.25582

Ejemplares similares